Literature DB >> 11744034

Mechanisms underlying maintenance of smooth muscle cell quiescence in rat aorta: role of the cyclin dependent kinases and their inhibitors.

Tanya D Izzard1, Christine Taylor, Sonia D Birkett, Christopher L Jackson, Andrew C Newby.   

Abstract

OBJECTIVE: We sought to understand why smooth muscle cell proliferation is effectively repressed in intact rat aortic tissue.
METHODS: Quiescent isolated rat aortic smooth muscle cells and segments of intact rat aorta were stimulated with 10% serum and the time course of expression and activity of proteins involved in cell cycle control were determined.
RESULTS: After serum stimulation, smooth muscle cells in intact aortic tissue exhibit no proliferation, whereas isolated cells entered S phase 14-16 h later. Activation of ERKs 1 and 2, and induction of cyclin D1 occurred both in isolated cells and aortic tissue. Regulation of Cdk4, cyclin E and Cdk2 protein levels was also not different. Levels of the cyclin-dependent kinase inhibitors (CKIs), p16 and p27, were initially high in quiescent isolated cells and tissue; levels were downregulated by serum in isolated cells but not in aortic tissue. Cyclin D1/Cdk4, and cyclin E/Cdk2 kinases were active before S phase entry in isolated cells, but remained inactive in aortic tissue.
CONCLUSIONS: Cell cycle entry is prevented in aortic tissue, and this is associated with an inability to downregulate p16 and p27 CKIs, and therefore to activate cyclin D1 and cyclin E associated kinase activities.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11744034     DOI: 10.1016/s0008-6363(01)00444-8

Source DB:  PubMed          Journal:  Cardiovasc Res        ISSN: 0008-6363            Impact factor:   10.787


  8 in total

1.  Derivation and maturation of synthetic and contractile vascular smooth muscle cells from human pluripotent stem cells.

Authors:  Maureen Wanjare; Frederick Kuo; Sharon Gerecht
Journal:  Cardiovasc Res       Date:  2012-10-11       Impact factor: 10.787

2.  MARCKS silencing differentially affects human vascular smooth muscle and endothelial cell phenotypes to inhibit neointimal hyperplasia in saphenous vein.

Authors:  Thomas S Monahan; Nicholas D Andersen; Michelle C Martin; Junaid Y Malek; Gautam V Shrikhande; Leena Pradhan; Christiane Ferran; Frank W LoGerfo
Journal:  FASEB J       Date:  2008-10-21       Impact factor: 5.191

3.  Deletion of Nrip1 delays skin aging by reducing adipose-derived mesenchymal stem cells (ADMSCs) senescence, and maintaining ADMSCs quiescence.

Authors:  Yu Hu; Yun Zhu; Skyler D Gerber; Jared M Osland; Min Chen; Krishna A Rao; Heng Gu; Rong Yuan
Journal:  Geroscience       Date:  2021-03-11       Impact factor: 7.713

4.  PKA and Epac synergistically inhibit smooth muscle cell proliferation.

Authors:  Richard C Hewer; Graciela B Sala-Newby; Yih-Jer Wu; Andrew C Newby; Mark Bond
Journal:  J Mol Cell Cardiol       Date:  2010-10-30       Impact factor: 5.000

5.  An Ex Vivo Vessel Injury Model to Study Remodeling.

Authors:  Mehmet H Kural; Guohao Dai; Laura E Niklason; Liqiong Gui
Journal:  Cell Transplant       Date:  2018-08-10       Impact factor: 4.064

6.  Soluble adenylyl cyclase links Ca2+ entry to Ca2+/cAMP-response element binding protein (CREB) activation in vascular smooth muscle.

Authors:  Tony Parker; Kai-Wen Wang; Declan Manning; Caroline Dart
Journal:  Sci Rep       Date:  2019-05-13       Impact factor: 4.379

Review 7.  Ending Restenosis: Inhibition of Vascular Smooth Muscle Cell Proliferation by cAMP.

Authors:  Sarah A Smith; Andrew C Newby; Mark Bond
Journal:  Cells       Date:  2019-11-16       Impact factor: 7.666

8.  S-phase kinase-associated protein-2 (Skp2) promotes vascular smooth muscle cell proliferation and neointima formation in vivo.

Authors:  Yih-Jer Wu; Graciela B Sala-Newby; Kuo-Tung Shu; Hung-I Yeh; Keiichi I Nakayama; Keiko Nakayama; Andrew C Newby; Mark Bond
Journal:  J Vasc Surg       Date:  2009-11       Impact factor: 4.268

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.